{"database": "open_comments", "table": "documents", "is_view": false, "human_description_en": "where agency_id = \"FDA\" and document_type = \"Other\" sorted by comment_end_date descending", "rows": [["FDA-2026-P-0749-0001", "FDA", "FDA-2026-P-0749", "Citizen Petition from Apotex Inc.", "Other", "Citizen Petition", "2026-01-26", 2026, 1, "2026-01-26", "2026-07-23", "2026-05-08 20:03:22", null, 1, 0, "09000064b9182c73"], ["FDA-2026-D-1255-0002", "FDA", "FDA-2026-D-1255", "Safety Assessment of Genome Editing in Human Gene Therapy Products Using Next-Generation Sequencing; Draft Guidance for Industry", "Other", "Guidance", "2026-04-15", 2026, 4, "2026-04-15", "2026-07-15", "2026-05-15 09:00:20", null, 1, 0, "09000064b9282a2a"], ["FDA-2025-D-6130-0002", "FDA", "FDA-2025-D-6130", "Establishing Impurity Specifications for Antibiotics; Draft Guidance for Industry", "Other", "Guidance", "2026-04-20", 2026, 4, "2026-04-20", "2026-06-23", "2026-05-18 09:00:19", null, 1, 0, "09000064b92940ac"], ["FDA-2025-D-7121-0002", "FDA", "FDA-2025-D-7121", "Compliance Policy Regarding Premarket and Other Requirements for Certain NIOSH Approved Air-Purifying Respirators; Draft Guidance for Industry and Food and Drug\nAdministration Staff", "Other", "Guidance", "2026-04-20", 2026, 4, "2026-04-20", "2026-06-23", "2026-05-06 09:00:15", null, 1, 0, "09000064b928d63f"], ["FDA-2021-D-0613-0003", "FDA", "FDA-2021-D-0613", "Stability Testing for Medicated Premixes (Revision 1); VICH GL8(R); Guidance for Industry; Draft Guidance; #91", "Other", "Guidance", "2026-04-16", 2026, 4, "2026-04-16", "2026-06-16", "2026-04-16 20:09:33", null, 1, 0, "09000064b9287b2e"], ["FDA-2025-D-2837-0002", "FDA", "FDA-2025-D-2837", "Questions and Answers About Requirements for Additional Traceability Records for Certain Foods: Guidance for Industry - Draft Guidance", "Other", "Guidance", "2026-02-20", 2026, 2, "2026-02-20", "2026-05-22", "2026-02-20 20:47:16", null, 1, 0, "09000064b91c9d9a"], ["FDA-2026-N-1304-0001", "FDA", "FDA-2026-N-1304", "Agenda for the U.S. Food and Drug Administration (FDA) Virtual Public Meeting Food Allergen Thresholds and Their Potential Applications 2-18-2026", "Other", "Agenda", "2026-02-18", 2026, 2, "2026-02-18", "2026-05-20", "2026-05-18 09:00:14", null, 1, 0, "09000064b91b5eeb"], ["FDA-2025-D-6131-0002", "FDA", "FDA-2025-D-6131", "General Considerations for the Use of New Approach Methodologies in Drug Development; Guidance for Industry - Draft Guidance", "Other", "Guidance", "2026-03-19", 2026, 3, "2026-03-19", "2026-05-19", "2026-05-18 09:00:15", null, 1, 0, "09000064b9223609"]], "truncated": false, "filtered_table_rows_count": 8, "expanded_columns": [], "expandable_columns": [], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "units": {}, "query": {"sql": "select id, agency_id, docket_id, title, document_type, subtype, posted_date, posted_year, posted_month, comment_start_date, comment_end_date, last_modified, fr_doc_num, open_for_comment, withdrawn, object_id from documents where \"agency_id\" = :p0 and \"document_type\" = :p1 order by comment_end_date desc limit 101", "params": {"p0": "FDA", "p1": "Other"}}, "facet_results": {"agency_id": {"name": "agency_id", "type": "column", "hideable": false, "toggle_url": "/open_comments/documents.json?agency_id=FDA&document_type=Other", "results": [{"value": "FDA", "label": "FDA", "count": 8, "toggle_url": "https://pawtectors.org/open_comments/documents.json?document_type=Other", "selected": true}], "truncated": false}, "document_type": {"name": "document_type", "type": "column", "hideable": false, "toggle_url": "/open_comments/documents.json?agency_id=FDA&document_type=Other", "results": [{"value": "Other", "label": "Other", "count": 8, "toggle_url": "https://pawtectors.org/open_comments/documents.json?agency_id=FDA", "selected": true}], "truncated": false}}, "suggested_facets": [{"name": "subtype", "toggle_url": "https://pawtectors.org/open_comments/documents.json?agency_id=FDA&document_type=Other&_facet=subtype"}, {"name": "posted_date", "toggle_url": "https://pawtectors.org/open_comments/documents.json?agency_id=FDA&document_type=Other&_facet=posted_date"}, {"name": "posted_month", "toggle_url": "https://pawtectors.org/open_comments/documents.json?agency_id=FDA&document_type=Other&_facet=posted_month"}, {"name": "comment_start_date", "toggle_url": "https://pawtectors.org/open_comments/documents.json?agency_id=FDA&document_type=Other&_facet=comment_start_date"}, {"name": "comment_end_date", "toggle_url": "https://pawtectors.org/open_comments/documents.json?agency_id=FDA&document_type=Other&_facet=comment_end_date"}, {"name": "posted_date", "type": "date", "toggle_url": "https://pawtectors.org/open_comments/documents.json?agency_id=FDA&document_type=Other&_facet_date=posted_date"}, {"name": "comment_start_date", "type": "date", "toggle_url": "https://pawtectors.org/open_comments/documents.json?agency_id=FDA&document_type=Other&_facet_date=comment_start_date"}, {"name": "comment_end_date", "type": "date", "toggle_url": "https://pawtectors.org/open_comments/documents.json?agency_id=FDA&document_type=Other&_facet_date=comment_end_date"}, {"name": "last_modified", "type": "date", "toggle_url": "https://pawtectors.org/open_comments/documents.json?agency_id=FDA&document_type=Other&_facet_date=last_modified"}], "next": null, "next_url": null, "private": false, "allow_execute_sql": true, "query_ms": 9.755861014127731, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}